发明申请
- 专利标题： Amylases for Pharmaceutical Use
- 专利标题（中）： 药用淀粉酶
-
申请号： US11917551申请日： 2006-06-16
-
公开(公告)号： US20090035293A1公开(公告)日： 2009-02-05
- 发明人: Allan Svendsen , Peter Collin Gregory
- 申请人： Allan Svendsen , Peter Collin Gregory
- 申请人地址： DK Bagsvaerd DE Hannover
- 专利权人： Novozymes A/S,Solvay Pharmaceuticals
- 当前专利权人： Novozymes A/S,Solvay Pharmaceuticals
- 当前专利权人地址： DK Bagsvaerd DE Hannover
- 优先权： DKPA200500931 20050624
- 国际申请： PCT/DK2006/000354 WO 20060616
- 主分类号： A61K38/43
- IPC分类号： A61K38/43 ; C12N9/26 ; A61P1/00
摘要：
The pharmaceutical use of amylases related to Bacillus alpha-amylases of SEQ ID NOs: 1-3, optionally in combination with a lipase and/or a protease. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The amylases of SEQ ID NOs: 1-3 are variants of amylases from Bacillus stearothermophilus, Bacillus licheniformis and Bacillus sp. The amylases of the invention have an improved efficacy in vivo, an improved pH-profile, a high specific activity, and/or an improved starch degradation profile.
公开/授权文献
- US08017351B2 Amylases for pharmaceutical use 公开/授权日：2011-09-13
信息查询
IPC分类:
